Gartner, Inc. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax
Gartner, Inc. (IT) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax of -$7.77 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-19.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax · last filed 2020-02-19
- Gartner, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2018-12-31 was -$24.40M.
- Gartner, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2018-09-30 was $350.00K.
- Gartner, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2012-12-31 was $1.06M, a 69.59% decline year-over-year.
- Gartner, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2012-09-30 was -$470.00K.
- Gartner, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2018 was -$7.77M, a 412.93% decline from fiscal 2017.
- Gartner, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2017 was $2.48M.
- Gartner, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2015 was -$1.34M, a 161.90% decline from fiscal 2014.
- Gartner, Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2014 was $2.16M, a 2.66% increase from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 9 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 12 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | -$24.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$24.05M derived: sum of 2 quarters · filed 2020-02-19 | -$7.77M 10-K · filed 2020-02-19 | ||
| 2018-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $16.63M 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | $16.28M 10-Q · filed 2018-08-01 | ||||
| 2017-12-31 | $2.48M 10-K · filed 2019-02-22 | ||||
| 2015-12-31 | -$1.34M 10-K · filed 2016-02-24 | ||||
| 2014-12-31 | $2.16M 10-K · filed 2016-02-24 | ||||
| 2013-12-31 | $2.11M 10-K · filed 2016-02-24 | ||||
| 2012-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $593.00K derived: sum of 2 quarters · filed 2015-02-27 | -$129.00K derived: sum of 3 quarters · filed 2015-02-27 | -$76.00K 10-K · filed 2015-02-27 | -$127.00K 10-K · filed 2013-02-22 |
| 2012-09-30 | -$470.00K 10-Q · filed 2012-11-06 | -$1.19M derived: sum of 2 quarters · filed 2012-11-06 | -$1.14M 10-Q · filed 2012-11-06 | $2.36M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-06-30 | -$722.00K 10-Q · filed 2012-08-03 | -$669.00K 10-Q · filed 2012-08-03 | $2.83M derived: sum of 3 quarters · filed 2014-02-26 | -$2.46M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-03-31 | $53.00K 10-Q · filed 2012-05-03 | $3.55M derived: sum of 2 quarters · filed 2014-02-26 | -$1.73M derived: sum of 3 quarters · filed 2014-02-26 | -$6.01M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2011-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$1.79M derived: sum of 2 quarters · filed 2014-02-26 | -$6.06M derived: sum of 3 quarters · filed 2014-02-26 | -$4.67M 10-K · filed 2014-02-26 | -$7.79M 10-K · filed 2013-02-22 |
| 2011-09-30 | -$5.28M 10-Q · filed 2012-11-06 | -$9.55M derived: sum of 2 quarters · filed 2012-11-06 | -$8.17M 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | -$4.27M 10-Q · filed 2012-08-03 | -$2.89M 10-Q · filed 2012-08-03 | |||
| 2011-03-31 | $1.38M 10-Q · filed 2012-05-03 | ||||
| 2010-12-31 | $6.24M 10-K · filed 2013-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |